Images are for illustrative purposes only.
Vilon
Vilon is the dipeptide Lys-Glu (KE), molecular weight approximately 275 Da, developed from research involving thymus-derived peptide fractions. It is proposed to modulate gene expression in immune cells, particularly lymphocytes and thymic epithelial cells, in the context of age-related immune decline.
At two residues and roughly 275 Da, Vilon is the smallest and lightest compound in the entire bioregulator series, which makes it a common structural reference point in discussions of how much sequence information a bioregulator actually requires. Its KE pair is also the opening of the KED group that Vesugen and Testagen (KED), Livagen (KEDA), Pancreagen (KEDW), and Prostamax (KEDP) build on. Vilon and Thymogen (Glu-Trp) are the series' only two dipeptides and both address immune tissue, differing in their second residue and in clinical development history. In vitro and animal studies examine lymphocyte function, immune-senescence parameters, and chromatin activity.
Supplied as a lyophilized 10-vial 20mg kit for in vitro research use only.